Phase 2 Study of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma (CSCC): Longer Follow-Up. J of Skin [Internet]. 2020 Oct. 27 [cited 2025 Apr. 19];4(6):s124. Available from: https://skin.dermsquared.com/skin/article/view/1097